Identification of the differential expression of serum microRNA in type 2 diabetes

Bioscience, Biotechnology and Biochemistry

Volumn 80, Issue 3, 2016, Pages 461-465

  Ding, Linchao ^a   Ai, Dongdong ^a   Wu, Ruihao ^a   Zhang, Tao ^a   Jing, Li ^a   Lu, Jianxin ^a   Zhong, Lianjin ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Microarray; MicroRNA; QRT PCR; Serum; T2DM

Indexed keywords

BODY FLUIDS; MICROARRAYS; POLYMERASE CHAIN REACTION;

MICRORNAS; POTENTIAL RESEARCHES; Q-RT-PCR; QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; SERUM; T2DM; TYPE 2 DIABETES MELLITUS;

RNA;

MICRORNA;

BLOOD; DNA MICROARRAY; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION STUDY;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84958959780     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1080/09168451.2015.1107460     Document Type: Article

References (34)

1. Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 2011;94:311-321.
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
3. Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death? Science. 2005;307:380-384.
4. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes. 2004;53: S16-S21.
5. Wadwa RP, Jaiswal M. Vascular measures to detect earlier macrovascular disease. Diabetes Technol. Ther. 2011;13: 1269-1270.
6. Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat. Rev. Endocrinol. 2013;9:513-521.
7. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Jama. 2003;289:76-79.
8. Guo L, Jiang F, Tang YT, et al. The Association of serum vascular endothelial growth factor and ferritin in diabetic microvascular disease. Diabetes Technol. Ther. 2014;16:224-234.
9. Li R, Zhang P, Barker LE, et al. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33:1872-1894.
10. Stark A, Brennecke J, Bushati N, et al. Animal microRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell. 2005;123:1133-1146.
11. Kloosterman WP, Plasterk RH. The diverse functions of micro- RNAs in animal development and disease. Dev. Cell. 2006;11:441-450.
12. Lee RC, Feinbaum RL, Ambros V, et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843-854.
13. Chin LJ, Slack FJ. A truth serum for cancer-microRNAs have major potential as cancer biomarkers. Cell Res. 2008;18: 983-984.
14. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997-1006.
15. Ajit SK. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors. 2012;12:3359-3369.
16. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. PNAS. 2008;105:10513-10518.
17. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. PNAS. 2011;108:5003-5008.
18. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE. 2008;3:e3694.
19. Gibbings DJ, Ciaudo C, Erhardt M, et al. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Bio. 2009;11:1143-1149.
20. Etheridge A, Lee I, Hood L, et al. Extracellular microRNA: a new source of biomarkers. Mutat. Res-Fund Mol. M. 2011;717:85-90.
21. Zhu W, Qin W, Atasoy U, et al. Circulating microRNAs in breast cancer and healthy subjects. BMC Res. Notes. 2009;2:89. doi: 10.1186/1756-0500-2-89.
22. Lawrie CH, Gal S, Dunlop HM, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. PNAS. 2009;106:4402-4407.
23. Ng EK, Chong WW, Jin H, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009;58:1375-1381.
24. Wang JF, Yu ML, Yu G, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem. Biophys. Res. Co. 2010;394:184-188.
25. Laterza OF, Lim L, Garrett-Engele PW, et al. Plasma micro- RNAs as sensitive and specific biomarkers of tissue injury. Clin. Chem. 2009;55:1977-1983.
26. Whitehead CL, Teh WT, Walker SP, et al. Circulating micro- RNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero. PLoS ONE. 2013;8:e78487.
27. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ. Res. 2012;110:483-495.
28. Jima DD, Zhang J, Jacobs C, et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood. 2010;116: e118-e127.
29. Hie M, Tsukamoto I. Increased expression of the receptor for activation of NF-êB and decreased runt-related transcription factor 2 expression in bone of rats with streptozotocin-induced diabetes. Int. J. Mol. Med. 2010;26:611-618.
30. Hu R, Liu W, Li H, et al. A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J. Biol. Chem. 2011;286:12328-12339.
31. Murata K, Yoshitomi H, Furu M, et al. MicroRNA-451 downregulates neutrophil chemotaxis via p38 MAPK. Arthritis Rheumatol. 2014;66:549-559.
32. Lim A, Nikolic-Paterson D, Ma F, et al. Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice. Diabetologia. 2009;52:347-358.
33. Zhang H, Li W, Nan F, et al. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line. Biochem. Biol. Res. Co. 2011;404:273-278.
34. Cummins JM, He Y, Leary RJ, et al. The colorectal microRNAome. PNAS. 2006;103:3687-3692.